Niagen Bioscience, Inc. Common Stock
Follow $NAGE
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $NAGE by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is NAGE moving today?
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
NAGE overview
Related filings and maps
Congress activity in NAGE
No receipt-qualified Congressional disclosure is present for NAGE in the cached public ledger.
NAGE contract awards, year to date.
Public federal awards linked to this ticker.
NAGE lobbying filings, year to date.
Registered lobbying filings matched to Niagen Bioscience, Inc. Common Stock.